JNJ News
Latest updates and analysis for Johnson & Johnson
January 2026
NewsJan 30
Johnson & Johnson Guidance
Guides significant oncology sales growth, potentially doubling near-term; supports strong long-term growth.
@MultibaggAIHQ on X
NewsJan 28
Biopharma Sentiment Snapped Higher
BPSI index jumped 78 to 90; aligns with price action and deal flow—continued M&A/IPOs expected.
@BowTiedBiotech on X
NewsJan 27
Hospitals in Correction Mode
Stocks down 20-30%; focus on below 20x EV/EBITDA with 20%+ growth—structural tailwind intact.
@EquityInsightss on X